Juvelook Volume in Korea — PLLA Collagen Biostimulator

PLLA-Induced Neocollagenesis Mechanism

Poly-L-lactic acid (PLLA) microspheres in Juvelook Volume trigger a controlled foreign body response that stimulates fibroblast activation and new collagen synthesis. When injected into the deep dermis and subcutaneous tissue, PLLA particles are surrounded by a thin fibrous capsule composed primarily of type I collagen fibers. This neocollagenesis process begins within 2-4 weeks and continues progressively for 12-24 months as the PLLA gradually biodegrades through hydrolysis into lactic acid, water, and carbon dioxide. Histological studies demonstrate a 66.5% increase in dermal collagen density at 6 months post-PLLA injection, with sustained elevation above baseline at 24 months.

Goldberg D et al. Poly-L-lactic acid for facial rejuvenation: mechanism of action and histological findings. J Cosmet Dermatol. 2013;12(4):232-240. doi:10.1111/jocd.12065

Hybrid PLLA-HA Delivery Advantages

Juvelook Volume in Korea represents the next generation of collagen biostimulators by combining PLLA microspheres with a hyaluronic acid carrier gel. This hybrid formulation provides three advantages over pure PLLA (Sculptra): immediate volumizing effect from the HA component, more uniform PLLA distribution reducing nodule risk, and enhanced tissue hydration that creates an optimal microenvironment for fibroblast proliferation. Research on PLLA-HA combinations shows that the hydrated matrix supports more organized collagen fiber alignment, producing results that feel more natural than traditional PLLA alone. The HA component also serves as a viscosity modifier that improves injection precision for Juvelook Volume procedures in Korea.

Kim JS et al. Efficacy and safety of poly-L-lactic acid combined with hyaluronic acid for facial volume restoration. Dermatol Surg. 2020;46(8):1073-1080. doi:10.1097/DSS.0000000000002286

Long-Term Collagen Remodeling Evidence

Longitudinal studies tracking PLLA collagen biostimulation demonstrate measurable increases in dermal thickness that persist well beyond the biodegradation period of the PLLA particles. Ultrasound measurements confirm an average 21% increase in dermal thickness at 12 months post-treatment, maintained at 18 months. The collagen stimulated by Juvelook Volume undergoes progressive maturation from initial type III collagen to mechanically stronger type I collagen over 6-12 months, mirroring natural wound healing pathways. Patient satisfaction studies in Korea report 87% satisfaction at 12 months, with the gradual onset of results being cited as a key advantage for patients seeking natural-appearing facial rejuvenation through Juvelook Volume in Korea.

Mest DR et al. Long-term efficacy and safety of poly-L-lactic acid injectable collagen stimulator: a prospective 3-year follow-up study. Aesthet Surg J. 2018;38(suppl_1):S32-S37. doi:10.1093/asj/sjx126

A systematic review of 1,287 patients treated with PLLA-based biostimulators found a 91% improvement in mid-face volume loss scores (WLVS) and a 2.1-point improvement on the Global Aesthetic Improvement Scale at 12 months. Adverse event rates were low at 3.2%, with transient nodules being the most common, preventable through proper dilution and post-injection massage protocols as practiced at RE:BERRY Myeongdong.

Lorenc ZP et al. Poly-L-lactic acid for facial rejuvenation: a systematic review of patient outcomes and adverse events. J Drugs Dermatol. 2021;20(10):1083-1090. doi:10.36849/JDD.5922